Relay Price Fair Value from 2010 to 2024

RLAY Stock  USD 7.50  0.36  4.58%   
Relay Therapeutics Price Fair Value yearly trend continues to be fairly stable with very little volatility. Price Fair Value will likely drop to 1.00 in 2024. During the period from 2010 to 2024, Relay Therapeutics Price Fair Value regression line of annual values had r-squared of  0.53 and arithmetic mean of  0.15. View All Fundamentals
 
Price Fair Value  
First Reported
2010-12-31
Previous Quarter
1.79463056
Current Value
1
Quarterly Volatility
1.44463119
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Relay Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Relay Therapeutics' main balance sheet or income statement drivers, such as Net Interest Income of 32.6 M, Interest Income of 32.6 M or Depreciation And Amortization of 4 M, as well as many indicators such as Price To Sales Ratio of 50.19, Dividend Yield of 0.0 or PTB Ratio of 1.0. Relay financial statements analysis is a perfect complement when working with Relay Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Relay Therapeutics Correlation against competitors.
For more information on how to buy Relay Stock please use our How to Invest in Relay Therapeutics guide.

Latest Relay Therapeutics' Price Fair Value Growth Pattern

Below is the plot of the Price Fair Value of Relay Therapeutics over the last few years. It is Relay Therapeutics' Price Fair Value historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Relay Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Price Fair Value10 Years Trend
Slightly volatile
   Price Fair Value   
       Timeline  

Relay Price Fair Value Regression Statistics

Arithmetic Mean0.15
Geometric Mean1.06
Coefficient Of Variation969.47
Mean Deviation1.25
Median(0.79)
Standard Deviation1.44
Sample Variance2.09
Range4.0858
R-Value0.73
Mean Square Error1.05
R-Squared0.53
Significance0
Slope0.24
Total Sum of Squares29.22

Relay Price Fair Value History

2024 1.0
2023 1.79
2022 1.76
2021 3.25
2020 2.32
2019 -0.83

About Relay Therapeutics Financial Statements

Relay Therapeutics investors use historical fundamental indicators, such as Relay Therapeutics' Price Fair Value, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Relay Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Price Fair Value 1.79  1.00 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Relay Stock Analysis

When running Relay Therapeutics' price analysis, check to measure Relay Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Relay Therapeutics is operating at the current time. Most of Relay Therapeutics' value examination focuses on studying past and present price action to predict the probability of Relay Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Relay Therapeutics' price. Additionally, you may evaluate how the addition of Relay Therapeutics to your portfolios can decrease your overall portfolio volatility.